Header Logo

Connection

Bryan James to Selegiline

Back to Details
This is a "connection" page, showing publications Bryan James has written about Selegiline.
Bryan James
Connection Strength
0.065
Selegiline
  1. Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication? Am J Geriatr Psychiatry. 2005 Nov; 13(11):1014-21.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.